These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease]. Dessibourg CA, Gachoud JP. Praxis (Bern 1994); 1995 Oct 24; 84(43):1235-8. PubMed ID: 7481341 [Abstract] [Full Text] [Related]
50. The hydrodynamically balanced system: a novel principle of controlled drug release. Erni W, Held K. Eur Neurol; 1987 Oct 24; 27 Suppl 1():21-7. PubMed ID: 3322836 [Abstract] [Full Text] [Related]
51. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa]. Fernández Pardal MM, Gatto E, Micheli F, Casas Parera I, Diaz S. Medicina (B Aires); 1991 Oct 24; 51(6):561-7. PubMed ID: 7476112 [Abstract] [Full Text] [Related]